Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 141 Pages
Report ld: 2700372
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2024-2030
-2.8%
Market Size,2030
USD 2
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3 million
Market Forecast in 2030(Value)
US$ 2 million
CAGR
-2.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market size was US$ 3 million in 2023 and is forecast to a readjusted size of US$ 2 million by 2030 with a CAGR of -2.8% during the forecast period 2024-2030.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
In terms of sales (consumption) side, this report focuses on the sales of Octreotide by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Octreotide market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Octreotide market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Octreotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Octreotide Definition
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market Segment by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Octreotide Sales
2.1 Global Octreotide Revenue Estimates and Forecasts 2019-2030
2.2 Global Octreotide Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Octreotide Revenue by Region
2.3.1 Global Octreotide Revenue by Region (2019-2024)
2.3.2 Global Octreotide Revenue by Region (2025-2030)
2.4 Global Octreotide Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Octreotide Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Octreotide Sales Quantity by Region
2.6.1 Global Octreotide Sales Quantity by Region (2019-2024)
2.6.2 Global Octreotide Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Octreotide Sales Quantity by Manufacturers
3.1.1 Global Octreotide Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Octreotide Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Octreotide Sales in 2023
3.2 Global Octreotide Revenue by Manufacturers
3.2.1 Global Octreotide Revenue by Manufacturers (2019-2024)
3.2.2 Global Octreotide Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Octreotide Revenue in 2023
3.3 Global Octreotide Sales Price by Manufacturers
3.4 Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Octreotide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Octreotide, Product Offered and Application
3.8 Global Key Manufacturers of Octreotide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Octreotide Sales Quantity by Type
4.1.1 Global Octreotide Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Octreotide Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Octreotide Sales Quantity Market Share by Type (2019-2030)
4.2 Global Octreotide Revenue by Type
4.2.1 Global Octreotide Historical Revenue by Type (2019-2024)
4.2.2 Global Octreotide Forecasted Revenue by Type (2025-2030)
4.2.3 Global Octreotide Revenue Market Share by Type (2019-2030)
4.3 Global Octreotide Price by Type
4.3.1 Global Octreotide Price by Type (2019-2024)
4.3.2 Global Octreotide Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Octreotide Sales Quantity by Application
5.1.1 Global Octreotide Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Octreotide Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Octreotide Sales Quantity Market Share by Application (2019-2030)
5.2 Global Octreotide Revenue by Application
5.2.1 Global Octreotide Historical Revenue by Application (2019-2024)
5.2.2 Global Octreotide Forecasted Revenue by Application (2025-2030)
5.2.3 Global Octreotide Revenue Market Share by Application (2019-2030)
5.3 Global Octreotide Price by Application
5.3.1 Global Octreotide Price by Application (2019-2024)
5.3.2 Global Octreotide Price Forecast by Application (2025-2030)
6 North America
6.1 North America Octreotide Sales by Company
6.1.1 North America Octreotide Revenue by Company (2019-2024)
6.1.2 North America Octreotide Sales Quantity by Company (2019-2024)
6.2 North America Octreotide Market Size by Type
6.2.1 North America Octreotide Sales Quantity by Type (2019-2030)
6.2.2 North America Octreotide Revenue by Type (2019-2030)
6.3 North America Octreotide Market Size by Application
6.3.1 North America Octreotide Sales Quantity by Application (2019-2030)
6.3.2 North America Octreotide Revenue by Application (2019-2030)
6.4 North America Octreotide Market Size by Country
6.4.1 North America Octreotide Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Octreotide Revenue by Country (2019-2030)
6.4.3 North America Octreotide Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Octreotide Sales by Company
7.1.1 Europe Octreotide Sales Quantity by Company (2019-2024)
7.1.2 Europe Octreotide Revenue by Company (2019-2024)
7.2 Europe Octreotide Market Size by Type
7.2.1 Europe Octreotide Sales Quantity by Type (2019-2030)
7.2.2 Europe Octreotide Revenue by Type (2019-2030)
7.3 Europe Octreotide Market Size by Application
7.3.1 Europe Octreotide Sales Quantity by Application (2019-2030)
7.3.2 Europe Octreotide Revenue by Application (2019-2030)
7.4 Europe Octreotide Market Size by Country
7.4.1 Europe Octreotide Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Octreotide Revenue by Country (2019-2030)
7.4.3 Europe Octreotide Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Octreotide Sales by Company
8.1.1 China Octreotide Sales Quantity by Company (2019-2024)
8.1.2 China Octreotide Revenue by Company (2019-2024)
8.2 China Octreotide Market Size by Type
8.2.1 China Octreotide Sales Quantity by Type (2019-2030)
8.2.2 China Octreotide Revenue by Type (2019-2030)
8.3 China Octreotide Market Size by Application
8.3.1 China Octreotide Sales Quantity by Application (2019-2030)
8.3.2 China Octreotide Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Octreotide Sales by Company
9.1.1 APAC Octreotide Sales Quantity by Company (2019-2024)
9.1.2 APAC Octreotide Revenue by Company (2019-2024)
9.2 APAC Octreotide Market Size by Type
9.2.1 APAC Octreotide Sales Quantity by Type (2019-2030)
9.2.2 APAC Octreotide Revenue by Type (2019-2030)
9.3 APAC Octreotide Market Size by Application
9.3.1 APAC Octreotide Sales Quantity by Application (2019-2030)
9.3.2 APAC Octreotide Revenue by Application (2019-2030)
9.4 APAC Octreotide Market Size by Region
9.4.1 APAC Octreotide Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Octreotide Revenue by Region (2019-2030)
9.4.3 APAC Octreotide Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Octreotide Sales by Company
10.1.1 Middle East, Africa and Latin America Octreotide Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Octreotide Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Octreotide Market Size by Type
10.2.1 Middle East, Africa and Latin America Octreotide Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Octreotide Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Octreotide Market Size by Application
10.3.1 Middle East, Africa and Latin America Octreotide Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Octreotide Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Octreotide Market Size by Country
10.4.1 Middle East, Africa and Latin America Octreotide Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Octreotide Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Octreotide Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Novartis Octreotide Products and Services
11.1.5 Novartis Octreotide SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Sun Pharmaceutical Octreotide Products and Services
11.2.5 Sun Pharmaceutical Octreotide SWOT Analysis
11.2.6 Sun Pharmaceutical Recent Developments
11.3 Chengdu Tiantaishan pharmaceutical
11.3.1 Chengdu Tiantaishan pharmaceutical Company Information
11.3.2 Chengdu Tiantaishan pharmaceutical Overview
11.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Products and Services
11.3.5 Chengdu Tiantaishan pharmaceutical Octreotide SWOT Analysis
11.3.6 Chengdu Tiantaishan pharmaceutical Recent Developments
11.4 Sinopharm A-Think Pharmaceuticals
11.4.1 Sinopharm A-Think Pharmaceuticals Company Information
11.4.2 Sinopharm A-Think Pharmaceuticals Overview
11.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Products and Services
11.4.5 Sinopharm A-Think Pharmaceuticals Octreotide SWOT Analysis
11.4.6 Sinopharm A-Think Pharmaceuticals Recent Developments
11.5 Sihuan Pharmaceutical Holdings Group
11.5.1 Sihuan Pharmaceutical Holdings Group Company Information
11.5.2 Sihuan Pharmaceutical Holdings Group Overview
11.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Products and Services
11.5.5 Sihuan Pharmaceutical Holdings Group Octreotide SWOT Analysis
11.5.6 Sihuan Pharmaceutical Holdings Group Recent Developments
11.6 Shanghai Soho-Yiming Pharmaceuticals
11.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
11.6.2 Shanghai Soho-Yiming Pharmaceuticals Overview
11.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products and Services
11.6.5 Shanghai Soho-Yiming Pharmaceuticals Octreotide SWOT Analysis
11.6.6 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
11.7 Yibin Pharmaceutical
11.7.1 Yibin Pharmaceutical Company Information
11.7.2 Yibin Pharmaceutical Overview
11.7.3 Yibin Pharmaceutical Octreotide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Yibin Pharmaceutical Octreotide Products and Services
11.7.5 Yibin Pharmaceutical Octreotide SWOT Analysis
11.7.6 Yibin Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Octreotide Value Chain Analysis
12.2 Octreotide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Octreotide Production Mode & Process
12.4 Octreotide Sales and Marketing
12.4.1 Octreotide Sales Channels
12.4.2 Octreotide Distributors
12.5 Octreotide Customers
13 Market Dynamics
13.1 Octreotide Industry Trends
13.2 Octreotide Market Drivers
13.3 Octreotide Market Challenges
13.4 Octreotide Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Octreotide Injection
Table 3. Major Manufacturers of Octreotide Powder
Table 4. Major Manufacturers of Octreotide Microspheres
Table 5. Global Octreotide Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Octreotide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Octreotide Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Octreotide Revenue Market Share by Region (2019-2024)
Table 9. Global Octreotide Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Octreotide Revenue Market Share by Region (2025-2030)
Table 11. Global Octreotide Sales Quantity by Region: 2019 VS 2023 VS 2030 (Gram)
Table 12. Global Octreotide Sales by Region (2019-2024) & (Gram)
Table 13. Global Octreotide Sales Market Share by Region (2019-2024)
Table 14. Global Octreotide Sales by Region (2025-2030) & (Gram)
Table 15. Global Octreotide Sales Market Share by Region (2025-2030)
Table 16. Global Octreotide Sales Quantity by Manufacturers (2019-2024) & (Gram)
Table 17. Global Octreotide Sales Quantity Share by Manufacturers (2019-2024)
Table 18. Global Octreotide Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Octreotide Revenue Share by Manufacturers (2019-2024)
Table 20. Global Octreotide Price by Manufacturers 2019-2024 (USD/Gram)
Table 21. Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023
Table 22. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Octreotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Octreotide as of 2023)
Table 24. Global Key Manufacturers of Octreotide, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Octreotide, Product Offered and Application
Table 26. Global Key Manufacturers of Octreotide, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 29. Global Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 30. Global Octreotide Sales Quantity Share by Type (2019-2024)
Table 31. Global Octreotide Sales Quantity Share by Type (2025-2030)
Table 32. Global Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Octreotide Revenue Share by Type (2019-2024)
Table 35. Global Octreotide Revenue Share by Type (2025-2030)
Table 36. Octreotide Price by Type (2019-2024) & (USD/Gram)
Table 37. Global Octreotide Price Forecast by Type (2025-2030) & (USD/Gram)
Table 38. Global Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 39. Global Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 40. Global Octreotide Sales Quantity Share by Application (2019-2024)
Table 41. Global Octreotide Sales Quantity Share by Application (2025-2030)
Table 42. Global Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Octreotide Revenue Share by Application (2019-2024)
Table 45. Global Octreotide Revenue Share by Application (2025-2030)
Table 46. Octreotide Price by Application (2019-2024) & (USD/Gram)
Table 47. Global Octreotide Price Forecast by Application (2025-2030) & (USD/Gram)
Table 48. North America Octreotide Revenue by Company (2019-2024) & (US$ Million)
Table 49. North America Octreotide Sales Quantity by Company (2019-2024) & (Gram)
Table 50. North America Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 51. North America Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 52. North America Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 53. North America Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 54. North America Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 55. North America Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 56. North America Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 57. North America Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 58. North America Octreotide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. North America Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 60. North America Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 61. North America Octreotide Sales Quantity by Country (2019-2024) & (Gram)
Table 62. North America Octreotide Sales Quantity by Country (2025-2030) & (Gram)
Table 63. Europe Octreotide Sales Quantity by Company (2019-2024) & (Gram)
Table 64. Europe Octreotide Revenue by Company (2019-2024) & (US$ Million)
Table 65. Europe Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 66. Europe Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 67. Europe Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 70. Europe Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 71. Europe Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Octreotide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Octreotide Sales Quantity by Country (2019-2024) & (Gram)
Table 77. Europe Octreotide Sales Quantity by Country (2025-2030) & (Gram)
Table 78. China Octreotide Sales Quantity by Company (2019-2024) & (Gram)
Table 79. China Octreotide Revenue by Company (2019-2024) & (US$ Million)
Table 80. China Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 81. China Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 82. China Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 83. China Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 84. China Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 85. China Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 86. China Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 87. China Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 88. APAC Octreotide Sales Quantity by Company (2019-2024) & (Gram)
Table 89. APAC Octreotide Revenue by Company (2019-2024) & (US$ Million)
Table 90. APAC Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 91. APAC Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 92. APAC Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 93. APAC Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 94. APAC Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 95. APAC Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 96. APAC Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 97. APAC Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 98. APAC Octreotide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 99. APAC Octreotide Revenue by Region (2019-2024) & (US$ Million)
Table 100. APAC Octreotide Revenue by Region (2025-2030) & (US$ Million)
Table 101. APAC Octreotide Sales Quantity by Region (2019-2024) & (Gram)
Table 102. APAC Octreotide Sales Quantity by Region (2025-2030) & (Gram)
Table 103. Middle East, Africa and Latin America Octreotide Sales Quantity by Company (2019-2024) & (Gram)
Table 104. Middle East, Africa and Latin America Octreotide Revenue by Company (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Octreotide Sales Quantity by Type (2019-2024) & (Gram)
Table 106. Middle East, Africa and Latin America Octreotide Sales Quantity by Type (2025-2030) & (Gram)
Table 107. Middle East, Africa and Latin America Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America Octreotide Sales Quantity by Application (2019-2024) & (Gram)
Table 110. Middle East, Africa and Latin America Octreotide Sales Quantity by Application (2025-2030) & (Gram)
Table 111. Middle East, Africa and Latin America Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 113. Middle East, Africa and Latin America Octreotide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 114. Middle East, Africa and Latin America Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 116. Middle East, Africa and Latin America Octreotide Sales Quantity by Country (2019-2024) & (Gram)
Table 117. Middle East, Africa and Latin America Octreotide Sales Quantity by Country (2025-2030) & (Gram)
Table 118. Novartis Company Information
Table 119. Novartis Description and Overview
Table 120. Novartis Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 121. Novartis Octreotide Product and Services
Table 122. Novartis Octreotide SWOT Analysis
Table 123. Novartis Recent Developments
Table 124. Sun Pharmaceutical Company Information
Table 125. Sun Pharmaceutical Description and Overview
Table 126. Sun Pharmaceutical Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 127. Sun Pharmaceutical Octreotide Product and Services
Table 128. Sun Pharmaceutical Octreotide SWOT Analysis
Table 129. Sun Pharmaceutical Recent Developments
Table 130. Chengdu Tiantaishan pharmaceutical Company Information
Table 131. Chengdu Tiantaishan pharmaceutical Description and Overview
Table 132. Chengdu Tiantaishan pharmaceutical Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 133. Chengdu Tiantaishan pharmaceutical Octreotide Product and Services
Table 134. Chengdu Tiantaishan pharmaceutical Octreotide SWOT Analysis
Table 135. Chengdu Tiantaishan pharmaceutical Recent Developments
Table 136. Sinopharm A-Think Pharmaceuticals Company Information
Table 137. Sinopharm A-Think Pharmaceuticals Description and Overview
Table 138. Sinopharm A-Think Pharmaceuticals Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 139. Sinopharm A-Think Pharmaceuticals Octreotide Product and Services
Table 140. Sinopharm A-Think Pharmaceuticals Octreotide SWOT Analysis
Table 141. Sinopharm A-Think Pharmaceuticals Recent Developments
Table 142. Sihuan Pharmaceutical Holdings Group Company Information
Table 143. Sihuan Pharmaceutical Holdings Group Description and Overview
Table 144. Sihuan Pharmaceutical Holdings Group Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 145. Sihuan Pharmaceutical Holdings Group Octreotide Product and Services
Table 146. Sihuan Pharmaceutical Holdings Group Octreotide SWOT Analysis
Table 147. Sihuan Pharmaceutical Holdings Group Recent Developments
Table 148. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 149. Shanghai Soho-Yiming Pharmaceuticals Description and Overview
Table 150. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 151. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product and Services
Table 152. Shanghai Soho-Yiming Pharmaceuticals Octreotide SWOT Analysis
Table 153. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
Table 154. Yibin Pharmaceutical Company Information
Table 155. Yibin Pharmaceutical Description and Overview
Table 156. Yibin Pharmaceutical Octreotide Sales Quantity (Gram), Revenue (US$ Million), Average Selling Price (ASP) (USD/Gram) and Gross Margin (2019-2024)
Table 157. Yibin Pharmaceutical Octreotide Product and Services
Table 158. Yibin Pharmaceutical Octreotide SWOT Analysis
Table 159. Yibin Pharmaceutical Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Octreotide Distributors List
Table 163. Octreotide Customers List
Table 164. Octreotide Market Trends
Table 165. Octreotide Market Drivers
Table 166. Octreotide Market Challenges
Table 167. Octreotide Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Octreotide Market Share by Type in 2023 & 2030
Figure 4. Octreotide Injection Product Picture
Figure 5. Octreotide Powder Product Picture
Figure 6. Octreotide Microspheres Product Picture
Figure 7. Global Octreotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Octreotide Market Share by Application in 2023 & 2030
Figure 9. Treating Severe Diarrhea
Figure 10. Treating Acromegaly
Figure 11. Others
Figure 12. Octreotide Report Years Considered
Figure 13. Global Octreotide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Octreotide Revenue 2019-2030 (US$ Million)
Figure 15. Global Octreotide Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Octreotide Sales Quantity 2019-2030 (Gram)
Figure 17. Global Octreotide Sales Quantity Market Share by Region (2019-2024)
Figure 18. Global Octreotide Sales Quantity Market Share by Region (2025-2030)
Figure 19. North America Octreotide Sales Quantity YoY (2019-2030) & (Gram)
Figure 20. North America Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Octreotide Sales Quantity YoY (2019-2030) & (Gram)
Figure 22. Europe Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Octreotide Sales Quantity YoY (2019-2030) & (Gram)
Figure 24. China Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 25. APAC Octreotide Sales Quantity YoY (2019-2030) & (Gram)
Figure 26. APAC Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Octreotide Sales Quantity YoY (2019-2030) & (Gram)
Figure 28. Middle East, Africa and Latin America Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Octreotide Sales Quantity in 2023
Figure 30. The Top 10 and Top 5 Players Market Share by Octreotide Revenue in 2023
Figure 31. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Octreotide Revenue Market Share by Type (2019-2030)
Figure 34. Global Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Octreotide Revenue Market Share by Application (2019-2030)
Figure 36. North America Octreotide Revenue Market Share by Company in 2023
Figure 37. North America Octreotide Sales Quantity Market Share by Company in 2023
Figure 38. North America Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Octreotide Revenue Market Share by Type (2019-2030)
Figure 40. North America Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Octreotide Revenue Market Share by Application (2019-2030)
Figure 42. North America Octreotide Revenue Share by Country (2019-2030)
Figure 43. North America Octreotide Sales Quantity Share by Country (2019-2030)
Figure 44. U.S. Octreotide Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Octreotide Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Octreotide Sales Quantity Market Share by Company in 2023
Figure 47. Europe Octreotide Revenue Market Share by Company in 2023
Figure 48. Europe Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 49. Europe Octreotide Revenue Market Share by Type (2019-2030)
Figure 50. Europe Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 51. Europe Octreotide Revenue Market Share by Application (2019-2030)
Figure 52. Europe Octreotide Revenue Share by Country (2019-2030)
Figure 53. Europe Octreotide Sales Quantity Share by Country (2019-2030)
Figure 54. Germany Octreotide Revenue (2019-2030) & (US$ Million)
Figure 55. France Octreotide Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Octreotide Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Octreotide Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Octreotide Revenue (2019-2030) & (US$ Million)
Figure 59. China Octreotide Sales Quantity Market Share by Company in 2023
Figure 60. China Octreotide Revenue Market Share by Company in 2023
Figure 61. China Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 62. China Octreotide Revenue Market Share by Type (2019-2030)
Figure 63. China Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 64. China Octreotide Revenue Market Share by Application (2019-2030)
Figure 65. APAC Octreotide Sales Quantity Market Share by Company in 2023
Figure 66. APAC Octreotide Revenue Market Share by Company in 2023
Figure 67. APAC Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 68. APAC Octreotide Revenue Market Share by Type (2019-2030)
Figure 69. APAC Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 70. APAC Octreotide Revenue Market Share by Application (2019-2030)
Figure 71. APAC Octreotide Revenue Share by Region (2019-2030)
Figure 72. APAC Octreotide Sales Quantity Share by Region (2019-2030)
Figure 73. Japan Octreotide Revenue (2019-2030) & (US$ Million)
Figure 74. South Korea Octreotide Revenue (2019-2030) & (US$ Million)
Figure 75. China Taiwan Octreotide Revenue (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Octreotide Revenue (2019-2030) & (US$ Million)
Figure 77. India Octreotide Revenue (2019-2030) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Octreotide Sales Quantity Market Share by Company in 2023
Figure 79. Middle East, Africa and Latin America Octreotide Revenue Market Share by Company in 2023
Figure 80. Middle East, Africa and Latin America Octreotide Sales Quantity Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Octreotide Revenue Market Share by Type (2019-2030)
Figure 82. Middle East, Africa and Latin America Octreotide Sales Quantity Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Octreotide Revenue Market Share by Application (2019-2030)
Figure 84. Middle East, Africa and Latin America Octreotide Sales Quantity Share by Country (2019-2030)
Figure 85. Middle East, Africa and Latin America Octreotide Revenue Share by Country (2019-2030)
Figure 86. Brazil Octreotide Revenue (2019-2030) & (US$ Million)
Figure 87. Mexico Octreotide Revenue (2019-2030) & (US$ Million)
Figure 88. Turkey Octreotide Revenue (2019-2030) & (US$ Million)
Figure 89. Israel Octreotide Revenue (2019-2030) & (US$ Million)
Figure 90. GCC Countries Octreotide Revenue (2019-2030) & (US$ Million)
Figure 91. Octreotide Value Chain
Figure 92. Octreotide Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Octreotide in 2024?
The global market size of Octreotide in 2024 was 3 Million USD.
What was the global market size of Octreotide in 2030?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Octreotide market size from 2024 to 2030?
Which companies rank high in the global Octreotide market?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now